Clinical trials: Gallbaldder Cancer
Biliary Tract Cancer
A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
The key aims of this study include estimation of possible risk associated with a history of gallstones, bacterial infection for the biliary tract, other medical history, diet, use of tobacco and alcohol, obesity, reproductive…
- Trial name
- NCT00339560
- Where
- China
- Volunteers
- 2,624 people
- Sponsor
- National Cancer Institute (NCI)
Gallbladder Cancer, Obstructive Jaundice
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer
Cancer of the gallbladder (CaGB) is one of the most common causes of malignant obstructive jaundice. Jaundice is the second most common presentation and occurs in 30-60% of patients with CaGB.
- Trial name
- NCT00409864
- Testing
- Endoscopic biliary stenting, Percutaneous biliary stenting
- Where
- India
- Volunteers
- 182 people
- Sponsor
- All India Institute of Medical Sciences
Gallbaldder Cancer
Initial Study of Gallbladder Cancer in Chile
Background: Chile has the highest diagnosis and death rates of gallbladder cancer in the world. Gallbladder cancer is also the leading cause of cancer death in Chilean women.
- Trial name
- NCT01520259
- Where
- 4 sites in Chile
- Volunteers
- 446 people
- Sponsor
- National Cancer Institute (NCI)
Gallbladder Cancer, Nutritional and Metabolic Diseases
Chile Biliary Longitudinal Study
Background: The gallbladder is a small organ below the liver. Gallbladder cancer is a leading cause of cancer death among women in Chile. Chile also has among the highest rates of gallbladder cancer and death in the world.
- Trial name
- NCT02692911
- Where
- 3 sites in Chile
- Volunteers
- 4,749 people, healthy volunteers welcome
- Sponsor
- National Cancer Institute (NCI)